$UG
UNITED GUARDIAN INC

2021 Q1 Form 10-Q Financial Statement

#000117184321003466 Filed on May 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $3.431M $3.323M
YoY Change 3.25% 4.48%
Cost Of Revenue $1.361M $1.389M
YoY Change -2.04% 7.84%
Gross Profit $2.070M $1.934M
YoY Change 7.05% 2.2%
Gross Profit Margin 60.33% 58.19%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $88.29K $107.7K
YoY Change -18.05% 9.2%
% of Gross Profit 4.27% 5.57%
Depreciation & Amortization $34.90K $40.52K
YoY Change -13.87% -3.77%
% of Gross Profit 1.69% 2.1%
Operating Expenses $88.29K $107.7K
YoY Change -18.05% -80.3%
Operating Profit $1.524M $1.311M
YoY Change 16.32% 5.15%
Interest Expense -$30.00K -$310.0K
YoY Change -90.32% -203.33%
% of Operating Profit -1.97% -23.65%
Other Income/Expense, Net -$32.29K -$312.5K
YoY Change -89.67% -203.71%
Pretax Income $1.492M $998.0K
YoY Change 49.51% -35.51%
Income Tax $311.0K $207.7K
% Of Pretax Income 20.84% 20.81%
Net Earnings $1.181M $790.3K
YoY Change 49.46% -35.36%
Net Earnings / Revenue 34.43% 23.78%
Basic Earnings Per Share $0.26
Diluted Earnings Per Share $0.26 $172.1K
COMMON SHARES
Basic Shares Outstanding 4.594M 4.594M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.070M $8.850M
YoY Change 2.49% -11.06%
Cash & Equivalents $862.0K $790.2K
Short-Term Investments $8.210M $8.060M
Other Short-Term Assets $340.0K $230.0K
YoY Change 47.83% -11.54%
Inventory $1.333M $1.363M
Prepaid Expenses
Receivables $1.904M $2.105M
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.65M $12.54M
YoY Change 0.89% -4.57%
LONG-TERM ASSETS
Property, Plant & Equipment $666.9K $744.9K
YoY Change -10.47% -7.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.12K
YoY Change -57.14%
Total Long-Term Assets $666.9K $756.1K
YoY Change -11.79% -8.74%
TOTAL ASSETS
Total Short-Term Assets $12.65M $12.54M
Total Long-Term Assets $666.9K $756.1K
Total Assets $13.32M $13.30M
YoY Change 0.17% -4.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.70K $32.09K
YoY Change 79.85% -77.48%
Accrued Expenses $1.494M $1.271M
YoY Change 17.55% -0.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.571M $1.572M
YoY Change -0.04% 0.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.571M $1.572M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.780M $1.870M
YoY Change -4.81% 2.75%
SHAREHOLDERS EQUITY
Retained Earnings $11.08M $10.96M
YoY Change 1.02% -6.2%
Common Stock $459.4K $459.4K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.54M $11.42M
YoY Change
Total Liabilities & Shareholders Equity $13.32M $13.30M
YoY Change 0.17% -4.81%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $1.181M $790.3K
YoY Change 49.46% -35.36%
Depreciation, Depletion And Amortization $34.90K $40.52K
YoY Change -13.87% -3.77%
Cash From Operating Activities $990.2K $1.287M
YoY Change -23.08% -15.95%
INVESTING ACTIVITIES
Capital Expenditures $28.16K $1.048K
YoY Change 2586.64% -91.93%
Acquisitions
YoY Change
Other Investing Activities -$690.0K -$1.540M
YoY Change -55.19% -1.91%
Cash From Investing Activities -$719.6K -$1.545M
YoY Change -53.44% -2.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities $990.2K 1.287M
Cash From Investing Activities -$719.6K -1.545M
Cash From Financing Activities
Net Change In Cash $270.6K -258.1K
YoY Change -204.84% 407.32%
FREE CASH FLOW
Cash From Operating Activities $990.2K $1.287M
Capital Expenditures $28.16K $1.048K
Free Cash Flow $962.1K $1.286M
YoY Change -25.2% -15.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
64032
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
59258
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
39760
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
44067
CY2021Q1 us-gaap Land
Land
69000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6795155
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6760255
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19292
CY2021Q1 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
33285
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
14017
CY2020Q4 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
63432
CY2021Q1 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
332669
CY2020Q4 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
325792
CY2021Q1 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
302959
CY2020Q4 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
302713
CY2021Q1 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
7978596
CY2020Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
7287151
CY2021Q1 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
8210779
CY2020Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
7591381
CY2021Q1 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
232183
CY2020Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
304230
CY2021Q1 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
232183
CY2020Q4 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
304230
CY2021Q1 ug Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
CY2020Q1 ug Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
-616
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
57704
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
31800
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1903737
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1387698
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
317100
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
210000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1494147
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1363457
CY2021Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
18971
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
149346
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
28125
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
50500
CY2021Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
214137
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
245521
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19292
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14017
CY2021Q1 us-gaap Assets
Assets
13320065
CY2020Q4 us-gaap Assets
Assets
11920276
CY2021Q1 us-gaap Assets Current
AssetsCurrent
12653144
CY2020Q4 us-gaap Assets Current
AssetsCurrent
11246611
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
459432
CY2021Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 27pt"><div style="display: inline; font-style: italic; font: inherit;">2.</div></td> <td style="text-align: justify">Basis of Presentation</td> </tr> </table> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">Interim condensed financial statements of the Company are prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;US GAAP&#x201d;) for interim financial information, pursuant to the requirements for reporting on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q and Regulation S-<div style="display: inline; font-style: italic; font: inherit;">X.</div> In the opinion of management, all adjustments considered necessary for the fair presentation of financial statements for the interim periods have been included. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 (</div>also referred to as the &#x201c;first quarter of <div style="display: inline; font-style: italic; font: inherit;">2021&#x201d;</div>) are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of results that ultimately <div style="display: inline; font-style: italic; font: inherit;"> may </div>be achieved for any other interim period or for the year ending <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2021. </div>The interim unaudited condensed financial statements and notes thereto should be read in conjunction with the audited condensed financial statements and notes thereto contained in our Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div></div>
CY2021Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2848585
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2848585
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
862049
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
591444
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
591444
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1048311
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
862049
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
790190
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
270605
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-258121
CY2021Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
989000
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
653000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
459432
CY2021Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
7978596
CY2020Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
7287151
CY2021Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4544491
CY2020Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4516335
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1361013
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1389331
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1906426
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
2012338
CY2021Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
248860
CY2020Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
291603
CY2021Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
100
CY2020Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
150
CY2021Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-72047
CY2020Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-356595
CY2021Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2020Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2021Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-72047
CY2020Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-356595
CY2021Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
61993
CY2020Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-84012
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
61993
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-84012
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
213677
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
151684
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
190164
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
32500
CY2020Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
36250
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
34900
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40519
CY2021Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
19028
CY2020Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
19028
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.26
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.17
CY2021Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
8210779
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
7591381
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1492155
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
998048
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
310953
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207741
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
200000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25904
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-39300
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
521314
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6025
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
126453
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
130690
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
141982
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-82938
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
145510
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
132389
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
57406
CY2021Q1 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-48960
CY2020Q1 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-165300
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
891840
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
941100
CY2021Q1 us-gaap Inventory Net
InventoryNet
1332835
CY2020Q4 us-gaap Inventory Net
InventoryNet
1415773
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
376963
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
415415
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000
CY2020Q4 us-gaap Land
Land
69000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13320065
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11920276
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1570879
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1414285
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8210779
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7591381
CY2021Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-72047
CY2020Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-356595
CY2021Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-72047
CY2020Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-356595
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-719601
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1545416
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
990206
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1287295
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1181202
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
790307
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32287
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-312528
CY2021Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
457127
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
515275
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1524442
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1310576
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24237
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16153
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
691445
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3544368
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28156
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1048
CY2021Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
32500
CY2020Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
293597
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
161208
CY2021Q1 us-gaap Prepaid Taxes
PrepaidTaxes
50147
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
99107
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2000000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7462076
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7433920
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
666921
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
673665
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5275
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-992
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
88286
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107732
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11076077
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
9894875
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3430868
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3322914
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11535509
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
10354307
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10632898
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11423205
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319

Files In Submission

Name View Source Status
0001171843-21-003466-index-headers.html Edgar Link pending
0001171843-21-003466-index.html Edgar Link pending
0001171843-21-003466.txt Edgar Link pending
0001171843-21-003466-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_32.htm Edgar Link pending
f10q_051321p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ug-20210331.xml Edgar Link completed
ug-20210331.xsd Edgar Link pending
ug-20210331_cal.xml Edgar Link unprocessable
ug-20210331_def.xml Edgar Link unprocessable
ug-20210331_lab.xml Edgar Link unprocessable
ug-20210331_pre.xml Edgar Link unprocessable